With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer||Baylor College of Medicine / Stephen Gottschalk, M.D.||Innovation Grants||2014||Texas|
|Building a Texas-based center for neuroblastoma clinical research.||Baylor College of Medicine / Heidi Russell, MD||Phase I/II Infrastructure Grants||2006||Texas|
|Center for Pediatric T Cell Therapy (CEPET)||Baylor College of Medicine / Cliona Rooney||Phase I/II Infrastructure Grants||2010||Texas|
|Immunotherapy for Osteosarcoma and Ewing sarcoma||Baylor College of Medicine / Nabil Ahmed, MD, MSc||Young Investigator Grants||2007||Texas|
|Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma||Baylor College of Medicine / Meenakshi Hegde, MD||'A' Award Grants||2016||Texas|
|Understanding the Role of a Novel Hereditary Cancer Gene||University of Texas Health Science Center at San Antonio / Patricia Dahia||Innovation Grants||2010||Texas|
|The Meaning of Adolescents' Eating Experiences during Bone Marrow Transplant Recovery.||Baylor College of Medicine / Cheryl Rodgers, PhD, RN||Nurse Researcher Grants||2007||Texas|
|Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation||Baylor College of Medicine / Eveline Barbiere, MD||Innovation Grants||2016||Texas|
|Screening for New Rhabdomyosaroma Pathogenesis Genes in a Drosophila Model||University of Texas Southwestern Medical Center / Kathleen Galindo||Young Investigator Grants||2012||Texas|
|Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2||Baylor College of Medicine / Andras Heczey, MD||Young Investigator Grants||2014||Texas|